Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 16;100(15):e25489.
doi: 10.1097/MD.0000000000025489.

Efficacy and safety of high-flow oxygen therapy application for chronic obstructive pulmonary disease with acute hypercapnic respiratory failure: A protocol for systematic review and meta-analysis

Mingxu Zheng  1 , Liangliang Dong, Zerui Hao, Shuyun Wang
Affiliations

Efficacy and safety of high-flow oxygen therapy application for chronic obstructive pulmonary disease with acute hypercapnic respiratory failure: A protocol for systematic review and meta-analysis

Mingxu Zheng et al. Medicine (Baltimore). .

Abstract

Background: Presently, there are no reviews or meta-analyses comparing the efficacy and safety of high-flow oxygen therapy (HFOT) and noninvasive ventilation (NIV) as first-line treatment in exacerbated chronic obstructive pulmonary disease (COPD) patients. The present protocol is conceived to evaluate whether HFOT is noninferior to NIV in treatment of patients with COPD and acute hypercapnic respiratory failure.

Methods: We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guidelines and the recommendations of the Cochrane Collaboration to conduct this meta-analysis. Reviewers will search the PubMed, Cochrane Library, Web of Science, and EMBASE online databases using the key phrases "high-flow oxygen therapy," "chronic obstructive pulmonary disease," and "acute hypercapnic respiratory failure" for all English-language cohort studies published up to April, 2021. The cohort studies focusing on assess the efficacy and safety of HFOT and NIV in the treatment of patients with COPD and acute hypercapnic respiratory failure will be included in our meta-analysis. The primary outcome is treatment failure, whereas the secondary outcomes included arterial blood gas analysis, dyspnea score, comfort score, mortality, and total ICU and hospital lengths of stay.

Results: The trial is conducted to test the hypothesis that HFOT, administered immediately after extubation, is not inferior to the NIV in reducing the rate of treatment failure in patients with COPD who were previously intubated due to hypercapniac respiratory failure.

Registration number: 10.17605/OSF.IO/Z2PEJ.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
Flow diagram of study identification.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ojo O, Lagan AL, Rajendran V, et al. . Pathological changes in the COPD lung mesenchyme - novel lessons learned from in vitro and in vivo studies. Pulm Pharmacol Ther 2014;29:121–8. - PubMed
    1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012;379:1341–51. - PMC - PubMed
    1. Tan WC, Mahayiddin AA, Charoenratanakul S, et al. . Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (UPDATE 2014) Global Initiative for Chronic Obstructive Lung Disease 2014 GOLD. Respirology 2005;10:09–17.
    1. Slenter RH, Sprooten RT, Kotz D, et al. . Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration 2013;85:15–26. - PubMed
    1. Li PJ, Wang T, Xiao J, et al. . Efficacy of two noninvasive weaning strategies in intubated patients with chronic obstructive pulmonary disease: a meta-analysis and indirect treatment comparison. Heart Lung 2016;45:132–9. - PubMed

MeSH terms